Exporter

EN
FR
Plazomicin
Statut de médicament essentiel
Description générale
Plazomicin is a next-generation aminoglycoside ("neoglycoside") used in the treatment of multi-drug resistant infections caused by carbapenem resistant Enterobacteriaceae, carbapenem-resistant Pseudomonas aeruginosa and carbapenem-resistant Acinetobacter baumannii.
INN
Plazomicin
Codes ATC
Type de médicament
Chemical agent
Groupes d'antibiotiques
Historique des statuts LME
Wikipédia
DrugBank
Recommandations
Section
Reserve group antibiotics
  • Parenteral > General injections > IV: 500 mg per 10 mL